Abizer Gaslightwala bought $20k of AKTX
CEO at Akari Therapeutics Plc. 21,000 shares at an average of $0.93, traded Aug 21, 2025, filed Aug 29, 2025.
Score components
- +25RoleCEO
- 0Trade size$20k at market
- +3Relative to holdingsHoldings up 8%
- +18Price context6% above the 52-week low; 74% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying4 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +27.6%, 3m -36.1%, 6m -68.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001641172-25-026025, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 21, 2025 | POpen-market purchase American Depositary Shares representing Ordinary Shares | +10,000 | $0.94 | $9,400 | 287,574 | Aug 29, 2025 |
| Aug 22, 2025 | POpen-market purchase American Depositary Shares representing Ordinary Shares | +8,000 | $0.93 | $7,440 | 295,574 | Aug 29, 2025 |
| Aug 25, 2025 | POpen-market purchase American Depositary Shares representing Ordinary Shares | +3,000 | $0.90 | $2,700 | 298,574 | Aug 29, 2025 |
Related signals
Other insiders at Akari Therapeutics Plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | AKTXbuy Akari Therapeutics Plc | Abizer Gaslightwala President & CEO | $7,120 6,146 shares | +2% | |
| 30Weak | AKTXbuy Akari Therapeutics Plc | Abizer Gaslightwala President & CEO | $12k 10,000 shares | +4% | |
| 28Weak | AKTXbuy Akari Therapeutics Plc | Abizer Gaslightwala President & CEO | $18k 15,000 shares | +6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.